HGH 191AA Results Timeline
What the standard HGH 191AA research protocol looks like phase by phase, over a typical 12–24 weeks cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYOnce daily (or 5 days on / 2 days off)
CYCLE LENGTH12–24 weeks
DOSE RANGE2–4 IU/day
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–4
Target dose: 2 IU
Escalation
Weeks 5–12
Target dose: 3 IU
Maintenance
Weeks 12+
Target dose: 4 IU
Reported in Research
- ✓12–24 weeks.
This timeline reflects the structure of the standard HGH 191AA research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.